VISIONS 2022, the national conference of the Foundation Fighting Blindness, is a one-of-a-kind event in which individuals who are blind or visually impaired, and their families, have the opportunity to hear about exciting advancements in blindness research. All attendees can gain practical skills for coping with vision loss, learn about products and services that can improve their lives, and connect with others from across the country.
The event will be held on Friday, June 17 – Saturday, June 18, 2022
The program is designed specifically for individuals and families who are affected by blinding retinal diseases such as age-related macular degeneration, retinitis pigmentosa, Usher syndrome, and related conditions. These diseases cause progressive blindness and affect more than 10 million Americans and millions more around the world.
More than 500 individuals in the visually impaired community are expected to attend this informative and encouraging conference. VISIONS 2022 provides the perfect backdrop for organizations offering low-vision products, services, and resources to meet with and market their brand to this targeted audience.
To learn more about the FFB and to register for the event, go to: https://www.fightingblindness.org/visions-2022
The Foundation Fighting Blindness was established in 1971 by a passionate group of families driven to find treatments and cures for inherited retinal diseases that were affecting their loved ones. At that time, little was known about these blinding retinal degenerative diseases. Very little research was being done, and there were no clinical trials for potential treatments.
The Foundation’s goal was clear and focused: To drive the research that would lead to preventions, treatments, and vision restoration for the spectrum of degenerative retinal diseases, specifically macular degeneration – including age related macular degeneration, retinitis pigmentosa, Usher syndrome, Stargardt disease and Leber congenital amaurosis (LCA). Together these conditions affect more than 10 million Americans and millions more throughout the world.
Today, the Foundation Fighting Blindness is the world’s leading private funder of retinal disease research. That funding has been a driving force behind the progress toward cures, including the identification of more than 270 genes linked to retinal disease, and the launch of over 40 clinical trials for potential treatments.
On an annual basis, the Foundation Fighting Blindness and the Foundation’s Clinical Research Institute fund more than 87 research grants. The research projects are conducted by more than 109 research investigators at 70 institutions, eye hospitals, and universities in the United States. The Foundation funding extends internationally to laboratories in Australia, Belgium, Brazil, Canada, Denmark, England, Finland, France, Germany, Israel, Italy, Mexico, the Netherlands, Poland, and Switzerland.
